We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
FMC and Corteva Partner to Expand Access to Rimisoxafen Technology
Read MoreHide Full Article
Key Takeaways
FMC and Corteva signed a co-exclusive deal to expand rimisoxafen access in the Americas.
Corteva will prepay $200 million as FMC retains ownership and supplies the active ingredient.
Rimisoxafen-based products are expected to see first commercial sales by decade's end.
FMC Corporation (FMC - Free Report) and Corteva, Inc. have announced a co-exclusive strategic supply and license agreement to expand access to FMC’s rimisoxafen herbicide technology across North and South America. The collaboration is expected to help herbicide-resistant weed management solutions for corn and soybean markets while adding to the portfolios of these two leading global agricultural science and innovation companies.
Under the agreement, FMC will retain ownership of rimisoxafen and supply the active ingredient to Corteva. Both companies will independently develop and commercialize exclusive premix formulations for corn and soybean markets throughout the region. Corteva will make an initial prepayment of $200 million for future product supply.
Rimisoxafen has been recognized by the Herbicide Resistance Action Committee as the industry’s first dual mode of action herbicide. Its unique design provides a higher barrier to resistance development compared to traditional single-mode of action products.
The partnership will play a critical role in broadening access to this groundbreaking innovation to control threats to crop yields and farm profitability. Pending regulatory approvals, the first commercial sales of rimisoxafen-based products are anticipated by the end of the decade. The partnership reflects both companies’ commitment to providing sustainable and effective weed management solutions for farmers across the Americas.
FMC shares have plunged 71.3% over the past year against the industry’s 2.9% growth.
Image Source: Zacks Investment Research
FMC’s Zacks Rank & Key Picks
FMC currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Basic Materials space are Albemarle Corporation (ALB - Free Report) , Dow Inc. (DOW - Free Report) and Avino Silver & Gold Mines Ltd. (ASM - Free Report) .
The Zacks Consensus Estimate for ALB’s 2026 earnings is pinned at $12.39 per share, indicating a 1,668.35% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed once, with an average surprise of 74.5%. ALB’s shares have jumped 180.4% over the past year.
The Zacks Consensus Estimate for DOW’s 2026 earnings is pegged at $2.61 per share, indicating a rise of 377.66% year over year. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters. DOW’sshares have gained 14.1% over the past year.
The Zacks Consensus Estimate for ASM’s current fiscal-year earnings is pinned at 39 cents per share, indicating a 34.48% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 125%.
View the Zacks #1 Rank List
Image: Bigstock
FMC and Corteva Partner to Expand Access to Rimisoxafen Technology
Key Takeaways
FMC Corporation (FMC - Free Report) and Corteva, Inc. have announced a co-exclusive strategic supply and license agreement to expand access to FMC’s rimisoxafen herbicide technology across North and South America. The collaboration is expected to help herbicide-resistant weed management solutions for corn and soybean markets while adding to the portfolios of these two leading global agricultural science and innovation companies.
Under the agreement, FMC will retain ownership of rimisoxafen and supply the active ingredient to Corteva. Both companies will independently develop and commercialize exclusive premix formulations for corn and soybean markets throughout the region. Corteva will make an initial prepayment of $200 million for future product supply.
Rimisoxafen has been recognized by the Herbicide Resistance Action Committee as the industry’s first dual mode of action herbicide. Its unique design provides a higher barrier to resistance development compared to traditional single-mode of action products.
The partnership will play a critical role in broadening access to this groundbreaking innovation to control threats to crop yields and farm profitability. Pending regulatory approvals, the first commercial sales of rimisoxafen-based products are anticipated by the end of the decade. The partnership reflects both companies’ commitment to providing sustainable and effective weed management solutions for farmers across the Americas.
FMC shares have plunged 71.3% over the past year against the industry’s 2.9% growth.
Image Source: Zacks Investment Research
FMC’s Zacks Rank & Key Picks
FMC currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks in the Basic Materials space are Albemarle Corporation (ALB - Free Report) , Dow Inc. (DOW - Free Report) and Avino Silver & Gold Mines Ltd. (ASM - Free Report) .
While ALB and DOW sport a Zacks Rank #1 (Strong Buy) each at present, ASM carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for ALB’s 2026 earnings is pinned at $12.39 per share, indicating a 1,668.35% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters and missed once, with an average surprise of 74.5%. ALB’s shares have jumped 180.4% over the past year.
The Zacks Consensus Estimate for DOW’s 2026 earnings is pegged at $2.61 per share, indicating a rise of 377.66% year over year. Its earnings beat the Zacks Consensus Estimate in three of the trailing four quarters. DOW’sshares have gained 14.1% over the past year.
The Zacks Consensus Estimate for ASM’s current fiscal-year earnings is pinned at 39 cents per share, indicating a 34.48% year-over-year increase. Its earnings beat the Zacks Consensus Estimate in each of the trailing four quarters, with an average surprise of 125%.